Item 2.02 Results of Operations and Financial Condition.
On March 26, 2020, TFF Pharmaceuticals, Inc. (the "Company") issued a press
release announcing its financial results for the fourth quarter and fiscal year
ended December 31, 2019. A copy of the press release is attached as Exhibit 99.1
to this Current Report and is incorporated herein by reference.
The information in this Item 2.02, including the press release attached as
Exhibit 99.1 hereto, is furnished pursuant to Item 2.02 but shall not be deemed
"filed" for any purpose, including for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to the liabilities of that Section, nor shall it be deemed to be
incorporated by reference into any filing under the Securities Act of 1933, as
amended, or the Exchange Act, whether made before or after the date hereof,
regardless of any general incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits Method Filing
The following exhibit is furnished with this report:
Exhibit 99.1 Press release dated March 26, 2020 Filed Electronically herewith
regarding the Registrant's financial
results for its fiscal quarter and year
ended December 31, 2019
© Edgar Online, source Glimpses